Does this generate a final CER or PSUR?
No. It creates a structured evidence and gap workpaper that can support controlled authoring and review.

Paste post-market and clinical evidence together so the agent can test the lifecycle links that static templates miss: complaints to signals, signals to risk, PMCF to clinical questions, and findings to CAPA and reports.
The agent separates supplied facts, documents, assumptions and unknowns.
Every finding stays tied to the evidence you actually supplied.
Turn the result into a practical worklist and save it as a branded PDF.
Paste a PMS plan, complaint/trend summary, vigilance and field-action data, literature-search status, PMCF plan or results, CER/PEP excerpts, PSUR/PMS report draft, and risk-file links.


Need help confirming a classification or planning your registration?
State the device, variants, class, markets, time on market and exposure or sales denominators when available.
Add the PMS plan, complaint and vigilance summaries, literature status, PMCF rationale or results, CER/PSUR conclusions, risk changes and CAPA links.
Move from this workpaper into the next connected review. Pasted evidence stays on this page and is never placed in a link.
Screen incident facts, reporting paths, health risk, field actions, and communications
Review hazards, controls, verification, residual risk, traceability, and post-market updates
Structure containment, root-cause hypotheses, actions, effectiveness, and risk linkage
No. It creates a structured evidence and gap workpaper that can support controlled authoring and review.
Yes, but rate and trend conclusions may be limited without a suitable denominator and time window.
No. It can review the rationale supplied and identify unanswered clinical questions, but the manufacturer must document and approve the final strategy.
It evaluates the actual text and data you paste, distinguishes evidence from plans, and checks links among PMS, clinical evaluation, risk management and CAPA.